Engineers Gate Manager LP Catalyst Biosciences, Inc. Transaction History

Engineers Gate Manager LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.51 - $1.0 $8,198 - $16,076	-16,076 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.91 - $4.16 $14,629 - $66,876	16,076 New	16,076 $15,000
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $74,210 - $96,473	-18,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $23,171 - $33,605	4,700 Added 35.07%	18,100 $91,000
Q4 2020 Feb 16, 2021	BUY	$4.55 - $7.29 $4,095 - $6,561	900 Added 7.2%	13,400 $85,000
Q3 2020 Nov 16, 2020	SELL	$4.22 - $6.04 $28,696 - $41,072	-6,800 Reduced 35.23%	12,500 $54,000
Q2 2020 Aug 17, 2020	BUY	$3.76 - $8.01 $24,064 - $51,264	6,400 Added 49.61%	19,300 $113,000
Q1 2020 May 15, 2020	BUY	$3.5 - $8.51 $45,150 - $109,779	12,900 New	12,900 $56,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.